Suppr超能文献

肠-肝轴在肝硬化免疫重塑中的作用。

The gut-liver axis in immune remodeling of hepatic cirrhosis.

机构信息

Department of Medicine and Therapeutics, State Key Laboratory of Digestive Disease, Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.

Department of Liver Surgery, Center of Hepato-Pancreato-Biliary Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.

出版信息

Front Immunol. 2022 Aug 8;13:946628. doi: 10.3389/fimmu.2022.946628. eCollection 2022.

Abstract

In healthy settings, the gut-liver axis allows host-microbiota communications and mediates immune homeostasis through bidirectional regulation. Meanwhile, in diseases, gut dysbiosis, combined with an impaired intestinal barrier, introduces pathogens and their toxic metabolites into the system, causing massive immune alternations in the liver and other extrahepatic organs. Accumulating evidence suggests that these immune changes are associated with the progression of many liver diseases, especially hepatic cirrhosis. Pathogen-associated molecular patterns that originated from gut microbes directly stimulate hepatocytes and liver immune cells through different pattern recognition receptors, a process further facilitated by damage-associated molecular patterns released from injured hepatocytes. Hepatic stellate cells, along with other immune cells, contribute to this proinflammatory and profibrogenic transformation. Moreover, cirrhosis-associated immune dysfunction, an imbalanced immune status characterized by systemic inflammation and immune deficiency, is linked to gut dysbiosis. Though the systemic inflammation hypothesis starts to link gut dysbiosis to decompensated cirrhosis from a clinical perspective, a clearer demonstration is still needed for the role of the gut-liver-immune axis in cirrhosis progression. This review discusses the different immune states of the gut-liver axis in both healthy and cirrhotic settings and, more importantly, summarizes the current evidence about how microbiota-derived immune remodeling contributes to the progression of hepatic cirrhosis the gut-liver axis.

摘要

在健康的环境中,肠道-肝脏轴允许宿主-微生物群落进行通讯,并通过双向调节来介导免疫稳态。与此同时,在疾病中,肠道菌群失调,加上肠道屏障受损,会将病原体及其有毒代谢物引入体内,导致肝脏和其他肝外器官的大量免疫改变。越来越多的证据表明,这些免疫变化与许多肝病的进展有关,尤其是肝硬化。源自肠道微生物的病原体相关分子模式通过不同的模式识别受体直接刺激肝细胞和肝脏免疫细胞,受损肝细胞释放的损伤相关分子模式进一步促进了这一过程。肝星状细胞与其他免疫细胞一起促进了这种促炎和促纤维化的转化。此外,与肝硬化相关的免疫功能障碍是一种以全身炎症和免疫缺陷为特征的免疫失衡状态,与肠道菌群失调有关。虽然系统炎症假说开始从临床角度将肠道菌群失调与失代偿性肝硬化联系起来,但仍需要更明确的证据来证明肠道-肝脏-免疫轴在肝硬化进展中的作用。这篇综述讨论了健康和肝硬化环境中肠道-肝脏轴的不同免疫状态,更重要的是,总结了目前关于微生物群衍生的免疫重塑如何促进肝硬化进展的证据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db80/10319400/f094365d0ce5/fimmu-13-946628-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验